Literature DB >> 22441934

Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.

Eleni Vakonaki1, Nikolaos Soulitzis, Stavros Sifakis, Danae Papadogianni, Dimitrios Koutroulakis, Demetrios A Spandidos.   

Abstract

PURPOSE: p63 plays an important role in several intracellular processes such as transcription activation and apoptosis. p63 has two N-terminal isoforms, TAp63 and ΔNp63. TAp63 isoform has p53-like functions, while ΔNp63 acts as a dominant negative inhibitor of the p53 family and is considered oncogenic. Although p63 and its isoforms are overexpressed in a wide variety of human malignancies such as cervical, head and neck, and lung cancer, their role in endometrial carcinoma has not been investigated.
METHODS: We measured by quantitative real-time polymerase chain reaction the mRNA expression of TAp63 and ΔNp63 in a series of 20 endometrioid adenocarcinomas paired with adjacent normal tissue.
RESULTS: TAp63 isoform exhibited 1.8-fold overexpression in malignant samples, while ΔNp63 was 4.3-fold overexpressed in cancer specimens. Further analysis revealed that the ΔN/TA isoform ratio shifted from 0.5 in normal samples to 1.2 in tumor specimens. Statistical analysis also revealed an association of TAp63 expression with high body mass index (p = 0.034), late menopause (p = 0.020), and lower tumor grade (p = 0.034). ΔNp63 was also correlated with grade I/II tumors (p = 0.044).
CONCLUSIONS: These results indicate that both p63 isoforms and especially ΔNp63 play an important role in the development and progression of grade I/II endometrial adenocarcinoma, especially in obese and late-menopause women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441934     DOI: 10.1007/s00432-012-1200-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

Review 1.  Role of p63 in cancer development.

Authors:  Vincenzo Graziano; Vincenzo De Laurenzi
Journal:  Biochim Biophys Acta       Date:  2011-04-15

2.  The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.

Authors:  Giancarlo Pruneri; Sonia Fabris; Patrizia Dell'Orto; Maria Olivia Biasi; Stefano Valentini; Barbara Del Curto; Daniele Laszlo; Laura Cattaneo; Roberta Fasani; Laura Rossini; Michela Manzotti; Francesco Bertolini; Giovanni Martinelli; Antonino Neri; Giuseppe Viale
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

3.  Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.

Authors:  Li-Yu Cao; Yu Yin; Hao Li; Yan Jiang; Hong-Fu Zhang
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

4.  TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.

Authors:  C Ruptier; A De Gaspéris; S Ansieau; A Granjon; P Tanière; I Lafosse; H Shi; A Petitjean; E Taranchon-Clermont; V Tribollet; T Voeltzel; J-Y Scoazec; V Maguer-Satta; A Puisieux; P Hainaut; C Cavard; C Caron de Fromentel
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

5.  Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.

Authors:  Ryota Matsubara; Shintaro Kawano; Takahiro Kiyosue; Yuichi Goto; Mitsuhiro Hirano; Teppei Jinno; Takeshi Toyoshima; Ryoji Kitamura; Kazunari Oobu; Seiji Nakamura
Journal:  Int J Oncol       Date:  2011-08-09       Impact factor: 5.650

6.  Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1.

Authors:  James S Lewis; Jon H Ritter; Samir El-Mofty
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

7.  Frequent alteration of p63 expression in human primary bladder carcinomas.

Authors:  B J Park; S J Lee; J I Kim; S J Lee; C H Lee; S G Chang; J H Park; S G Chi
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.

Authors:  Helene Geddert; Sibylle Kiel; Hans Jörg Heep; Helmut Erich Gabbert; Mario Sarbia
Journal:  Hum Pathol       Date:  2003-09       Impact factor: 3.466

Review 9.  p73 and p63 protein stability: the way to regulate function?

Authors:  Carine Maisse; Piero Guerrieri; Gerry Melino
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

Review 10.  Functional regulation of p73 and p63: development and cancer.

Authors:  Gerry Melino; Xin Lu; Milena Gasco; Tim Crook; Richard A Knight
Journal:  Trends Biochem Sci       Date:  2003-12       Impact factor: 13.807

View more
  3 in total

1.  Interleukin-17A mediates tobacco smoke-induced lung cancer epithelial-mesenchymal transition through transcriptional regulation of ΔNp63α on miR-19.

Authors:  Chunfeng Xie; Jianyun Zhu; Cong Huang; Xue Yang; Xiaoqian Wang; Yu Meng; Shanshan Geng; Jieshu Wu; Hongbin Shen; Zhibin Hu; Zili Meng; Xiaoting Li; Caiyun Zhong
Journal:  Cell Biol Toxicol       Date:  2021-04-03       Impact factor: 6.691

2.  Differentially Expressed Genes in EEC and LMS Syndromes.

Authors:  Wei Yin; Yaling Song; Yangge Du; Zhuan Bian
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

3.  ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.

Authors:  Sunyoung Park; Suji Lee; Jungho Kim; Geehyuk Kim; Kwang Hwa Park; Tae Ue Kim; Dawn Chung; Hyeyoung Lee
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.